Microscaled proteogenomic methods for precision oncology
Connecting genomics and proteomics allows the development of more efficient and specific treatments for cancer. Here, the authors develop proteogenomic methods to defining cancer signaling in-vivo starting from core needle biopsies and with application to a HER2 breast cancer focused clinical trial.
Guardado en:
Autores principales: | Shankha Satpathy, Eric J. Jaehnig, Karsten Krug, Beom-Jun Kim, Alexander B. Saltzman, Doug W. Chan, Kimberly R. Holloway, Meenakshi Anurag, Chen Huang, Purba Singh, Ari Gao, Noel Namai, Yongchao Dou, Bo Wen, Suhas V. Vasaikar, David Mutch, Mark A. Watson, Cynthia Ma, Foluso O. Ademuyiwa, Mothaffar F. Rimawi, Rachel Schiff, Jeremy Hoog, Samuel Jacobs, Anna Malovannaya, Terry Hyslop, Karl R. Clauser, D. R. Mani, Charles M. Perou, George Miles, Bing Zhang, Michael A. Gillette, Steven A. Carr, Matthew J. Ellis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1139337b9d47460b818a84e3816a1de9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
por: Kuan-lin Huang, et al.
Publicado: (2017) -
Correction: Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
por: Kuan-lin Huang, et al.
Publicado: (2017) -
Nanoscaled and microscaled parallel topography promotes tenogenic differentiation of ASC and neotendon formation in vitro
por: Zhou KL, et al.
Publicado: (2018) -
Proteogenomic analysis of pancreatic cancer subtypes.
por: Doris Kafita, et al.
Publicado: (2021) -
Breast cancer quantitative proteome and proteogenomic landscape
por: Henrik J. Johansson, et al.
Publicado: (2019)